Atlas Trials

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis

Clinical trial NCT00222222 · COMPLETED

Trial details

NCT number
NCT00222222
Sponsor
Universitätsmedizin Mannheim
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Sepsis
Start date
2003-03-01
Primary completion
2011-12-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.